Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Observational Study of Rivaroxaban Adherence and Effectiveness in High-Risk Atrial Fibrillation
ChiCTR2100042086Phase 4Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of rivaroxaban in Atrial fibrillation (AFib), sponsored by West China Hospital of Sichuan University. Primary endpoint: Medication adherence to rivaroxaban. Started Jan 2021; status: recruiting.
02
Drugs
rivaroxaban
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on ChiCTR2100042086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2100042086.